Early graft loss secondary to massive hemorrhagic necrosis following orthotopic liver transplantation. Evidence for cytokine-mediated univisceral shwartzman reaction

Transplantation

Volumn 61, Issue 9, 1996, Pages 1370-1376

  Burke, George W ^a,b   Cirocco, Robert ^b   Viciana, Ana ^b   Ruiz, Phillip ^b   Markou, Michael ^b   Allouch, Mustafa ^b   Ciancio, Gaetano ^b   Reddy, Rajender ^a   Jeffers, Lennox ^a   Schiff, Eugene ^a   Nery, Jose ^b   Miller, Joshua ^a   Tzakis, Andreas G ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLOGRAFT; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CELL INFILTRATION; COMPLEMENT DEPENDENT CYTOTOXICITY; FEMALE; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMAN; LIVER NECROSIS; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; SHWARTZMAN PHENOMENON; TRANSAMINATION;

ADULT; FEMALE; GRAFT SURVIVAL; HEMORRHAGE; HEPATITIS B; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NECROSIS; TIME FACTORS;

EID: 0029988190     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199605150-00015     Document Type: Article

References (49)

1. Burke G, Ascher N, Hunter D, Najarian JS. Orthotopic liver transplantation: non-operative management of early acute portal vein thrombosis. Surgery 1988; 104(5): 924.
2. Imagawa DK, Noguchi K, Iwaki Y, Busuttil RW. Hyperacute rejection following ABO-compatible orthotopic liver transplantation - a case report. Transplantation 1992; 54(6): 1114.
3. Demetris J, Jaffe R, Tzakis A, et al. Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. Am J Pathol 1988; 132(3): 489.
4. Hubscher SG, Adams DH, Buckels JAC, McMaster P, Neuberger J, Elias E. Massive haemorrhagic necrosis of the liver after liver transplantation. J Clin Pathol 1989; 42: 360.
5. Burke GW, Cirocco R, Nery J, et al. Serum cytokine levels in massive hemorrhagic necrosis following orthotopic liver transplantation. Rise in gamma interferon precedes rise in transaminases [Abstract 919]. Hepatology 1992; 16(4 Pt 2): 274A.
6. Shwartzman G. Studies on bacillus typhosus toxic substances. I. Phenomenon of local skin reactivity to B typhosus culture filtrate. J Exp Med 1928; 48: 247.
7. Brozna JP. Shwartzman reaction. Semin Thromb Hemost 1990; 16: 326.
8. Mori W, Shiga J, Kato A. Extensive hepatic cell necrosis produced by the Shwartzman mechanism. Virchows Arch A 1979; 382: 179.
9. Billiau A, Heremans H, Vandeckerckhove F, Dillen C. Anti-interferon-γ antibody protects mice against the generalized Shwartzman reaction. Eur J Immunol 1987; 17: 1851.
10. Grau GE, Vesin C, De Groote D, et al. Prevention of human TNF-induced cutaneous Shwartzman reaction and acute mortality in mice treated with anti-human TNF monoclonal antibodies. Clin Exp Immunol 1991; 84: 411.
11. Burke GW, Cirocco R, Markou M, et al. Acute graft loss secondary to necrotizing vasculitis. Evidence for cytokine-mediated Shwartzman reaction in clinical kidney transplantation. Transplantation 1995; 59(8): 1100.
12. Thai NL, Fu F, Qian S, et al. Cytokine mRNA profiles in mouse orthotopic liver transplantation. Graft rejection is associated with augmented TH1 function. Transplantation 1995; 59(2): 274.
13. Cosenza CA, Shirwan H, Cramer DV, Sher L, Podesta L, Makowka L. Intragraft cytokine gene expression in human liver allografts. Liver Transplant Surg 1995; 61(1): 16.
14. Imagawa DK, Millis JM, Olthoff KM, et al. The role of tumor necrosis factor in allograft rejection. I. Evidence that elevated levels of tumor necrosis factor-alpha predict rejection following orthotopic liver transplantation. Transplantation 1990; 50: 219.
15. Hoffmann MW, Wonigeit K, Steinhoff G, Herzbeck H, Flad HD, Pichlmayr R. Production of cytokines (TNF-α, IL-1-β) and endothelial cell activation in human liver allograft rejection. Transplantation 1993; 55(2): 329.
16. Monta M, Watanabe Y, Akaike T. Protective effect of hepatocyte growth factor on interferon-gamma-induced cytotoxicity in mouse hepatocytes. Hepatology 1995; 21: 1585.
17. Hathaway M, Burnett D, Elias E, Adams DH. Secretion of soluble chemotactic factors, including interleukin-6: a mechanism for the recruitment of CD8-positive T lymphocytes to human liver allografts during rejection. Hepatology 1993; 18: 511.
18. Tilg H, Ceska M, Vogel W, Herold M, Margreiter R, Huber C. Interleukin-8 serum concentrations after liver transplantation. Transplantation 1992; 53(4): 800.
19. Devlin J, Palmer RMJ, Gonde CE, et al. Nitric oxide generation. A predictive parameter of acute allograft rejection. Transplantation 1994; 58(5): 592.
20. Miyata T, Todo S, Selvy R, Yokoyama I, Tzakis A, Starzl TE. Endotoxaemia, pulmonary complications, and thrombocytopenia in liver transplantation. Lancet 1989; 2: 189.
21. Goto M, Takei Y, Kawano S, et al. Tumor necrosis factor and endotoxin in the pathogenesis of liver and pulmonary injuries after orthotopic liver transplantation in the rat. Hepatology 1992; 16: 487.
22. Dofferhoff ASM, De Jong HJ, Bom VJJ, et al. Complement activation and the production of inflammatory mediators during the treatment of severe sepsis in humans. Scand J Infect Dis 1992; 24: 197.
23. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993; 103: 565.
24. Zivot JB, Hoffman WD. Pathogenic effects of endotoxin. New Horizons 1995; 3: 267.
25. Nussler AK, DiSilvio M, Liu ZZ, et al. Further characterization and comparison of inducible nitric oxide synthase in mouse, rat, and human hepatocytes. Hepatology 1995; 21: 1552.
26. Harbrecht BG, DiSilvio M, Demetris AJ, Simmons RL, Billiar TR. Tumor necrosis factor-α regulates in vivo nitric oxide synthesis and induces liver injury during endotoxemia. Hepatology 1994; 20: 1055.
27. Bhagwandeen BS, Apte M, Manwarring L, Dickeson J. Endotoxin induced hepatic necrosis in rats on an alcohol diet. J Pathol 1987; 151: 47.
28. Nakao A, Taki S, Yasui M, et al. The fate of intravenously injected endotoxin in normal rats and in rats with liver failure. Hepatology 1994; 19: 1251.
29. Tiegs G, Wolter M, Wendel A. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol 1989; 38(4): 627.
30. Green S, Dobrjansky A, Chiasson MA, Carswell E, Schwartz MK, Old LJ. Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse. J Natl Cancer Inst 1979; 59: 1519.
31. Liu P, Ohnishi H, Moriwaki H, Muto Y. Enhanced tumor necrosis factor and interleukin-1 in an experimental model of massive liver cell necrosis/fatal hepatitis in mice. Gastroenterol Jpn 1990; 25: 339.
32. Shinagawa T, Yoshioka K, Kakumu S, et al. Apoptosis in cultured rat hepatocytes: the effects of tumor necrosis factor α and interferon γ. J Pathol 1991; 165: 247.
33. Luo D, Vanderkerken K, Bouwens L, Kuppen PJK, Crabbe E, Wisse E. The number and distribution of hepatic natural killer cells (pit cells) in normal rat liver: an immunohistochemical study. Hepatology 1995; 21: 1690.
34. Patel T, Gores GJ. Apoptosis and hepatobiliary disease. Hepatology 1995; 21(6): 1725.
35. Azoulay D, Astarcioglu I, Lemoine A, et al. The effects of donor and recipient endotoxemia on TNFα production and mortality in the rat model of syngenic orthotopic liver transplantation. Transplantation 1995; 59(6): 825.
36. Colleti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA. The role of tumor necrosis factor alpha in the pathophysiologic alterations following hepatic ischemia/reperfusion injury. J Clin Invest 1990; 85: 1936.
37. Sayegh MH, Watschinger B, Carpenter CB. Mechanisms of T cell recognition of alloantigen. Transplantation 1994; 57(9): 1295.
38. D'Orazio JA, Burke GW, Stein-Streilein J. Staphylococcal enterotoxin B activates purified NK cells to secrete IFN-γ but requires T lymphocytes to augment NK cytotoxicity. J Immunol 1995; 154: 1014.
39. Mori W, Aoki N, Shiga J. Acute hepatic cell necrosis experimentally produced by viral agents in rabbits. Am J Pathol 1981; 103: 31.
40. Gilles PN, Guerrette DL, Ulevitch RJ, Schreiber RD, Chisari FV. HBsAg retention sensitizes the hepatocyte to injury by physiological concentrations of interferon-γ. Hepatology 1992; 16: 655.
41. Cabie A, Farkas JC, Fitting C, et al. High levels of portal TNF-α during abdominal aortic surgery in man. Cytokine 1993; 5(5): 448.
42. Garside P, Bunce C, Tomlinson RC, Nichols BL, Mowat A McI. Analysis of enteropathy induced by tumour necrosis factor α. Cytokine 1993; 5(1): 24.
43. Argenbright LW, Barton RW. The Shwartzman response: a model of ICAM-1 dependent vasculitis. Agents Actions 1991; 34: 208.
44. Argenbright LW, Letts LG, Rothlein R. Monoclonal antibodies to the leukocyte membrane CD 18 glycoprotein complex and to intercellular adhesion molecule-1 inhibit leukocyte-endothelial adhesion in rabbits. J Leukoc Biol 1991; 49: 253.
45. Peng XX, Currin RT, Thurman RG, Lemasters JJ. Protection by pentoxifylline against normothermic liver ischemia/reperfusion in rats. Transplantation 1995; 59(11): 1537.
46. Rice GC, Brown PA, Nelson RJ, Bianco JA, Singer JW, Bursten S. Protection from endotoxic shock in mice by pharmacologic inhibition of phosphatidic acid. Proc Natl Acad Sci USA 1994; 91: 3857.
47. Manez R, Jain A, Marino IR, Thomson AW. Comparative evaluation of tacrolimus (FK506) and cyclosporine A as immunosuppressive agents. Transplant Rev 1995; 9(2): 63.
48. Tzakis A, Todo S, Starzl TE. Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg 1989; 210(5): 649.
49. Nakano H, Kuzume M, Namatame K, Yamaguchi M, Kumada K. Efficacy of intraportal injection of anti-ICAM-1 monoclonal antibody against liver cell injury following warm ischemia in the rat. Am J Surg 1995; 170: 64.